Skip to search formSkip to main contentSkip to account menu

Cholinesterase Inhibitor [EPC]

Known as: Acetylcholinesterase Inhibitor, Cholinesterase Inhibitor 
National Institutes of Health

Related topics

Related topics

2 relations
Acetylcholinesterase InhibitorsCholinesterase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Adjuvant Anticholinesterase Therapy for the Management of Epilepsy‐Induced Memory Deficit: A Critical Pre‐clinical Study
Epilepsy is one of the major neurological disorders still awaiting safer drugs with improved antiepileptic effect and lesser side… 
2013
2013
NEUROPROTECTIVE EFFECT OF RESVERATROL AGAINST SCOPOLAMINE-INDUCED COGNITIVE IMPAIRMENT AND OXIDATIVE STRESS IN RATS
The objective of this study was to examine the neuroprotective effect of resveratrol on cognitive impairment induced by… 
2012
2012
The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells.
Cognitive deficits in AD correlate with progressive synaptic dysfunction and loss. The Rho family of small GTPases, including Rho… 
Highly Cited
2010
Highly Cited
2010
Cryptotanshinone, an acetylcholinesterase inhibitor from Salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in Morris water maze task.
Alzheimer's disease (AD) is a common form of dementia which is characterized by the deposition of amyloids in affected neurons… 
2009
2009
Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
The present invention relates to a combination of alpha -7 nicotinic receptor partial agonist and an acetylcholinesterase… 
2007
2007
Scopolamine Induces Disruption of Latent Inhibition which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor
The fact that muscarinic antagonists may evoke a psychotic state (‘antimuscarinic psychosis’), along with findings of cholinergic… 
2006
2006
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease
2005
2005
Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice
The effects of galanthamine, a long-acting acetylcholinesterase inhibitor, on passive avoidance and a modified Morris swim task… 
1996
1996
α2-Adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat
The cholinergic hypothesis of Alzheimer's disease (AD) has strongly influenced research on learning and memory over the last… 
1984
1984
Noncholinesterase actions of an irreversible acetylcholinesterase inhibitor on synaptic transmission and membrane properties in autonomic ganglia
Summary1.Superfusion of the organophosphorous acetylcholinesterase inhibitor soman (pinacolyl methylphosphonofluoridate; 0.01–25… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)